Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinomas

Cancer Research

Volumn 61, Issue 13, 2001, Pages 5215-5222

  Wiesener, Michael S ^a   Münchenhagen, Philine M ^a   Schwiertz, Andreas ^a   Jürgensen, Jan Steffen ^a   Gruber, Gertrud ^a   Frei, Ulrich ^a   Eckardt, Kai Uwe ^a   Roigas, Jan ^a   Löning, Stefan A ^a   Berger, Irina ^b   Gröne, Hermann Josef ^b   Morgan, Neil V ^c   Maher, Eamonn R ^c   Maxwell, Patrick H ^d  

^a HUMBOLDT UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GLUCOSE TRANSPORTER; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ARTICLE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; GENE ACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, CLEAR CELL; CARCINOMA, RENAL CELL; CELL HYPOXIA; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LIGASES; LYMPHOKINES; MONOSACCHARIDE TRANSPORT PROTEINS; NUCLEAR PROTEINS; PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0035394516     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Oncogenic alterations of metabolism
2. Oxygen sensing and molecular adaptation to hypoxia
3. 2 homeostasis by hypoxia-inducible factor 1
4. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions
5. 2-dependent degradation domain via the ubiquitin-proteasome pathway
6. Oxygen(es) and the hypoxia-inducible factor-1
7. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
8. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression
9. HIF-1α is required for solid tumor formation and embryonic vascularization
10. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth
11. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation, and tumor angiogenesis
12. Suppression of tumor growth through disruption of hypoxia-inducible transcription
13. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
14. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
15. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein
16. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene
17. The turnout suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
18. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
19. Von Hippel-Lindau disease
20. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway
21. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
22. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein
23. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
24. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas)
25. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1α
26. Identification of the renal erythropoietin-producing cells using transgenic mice
27. Molecular genetic investigation of sporadic renal cell carcinoma: Analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22
28. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL-independent pathway in clear cell renal tumourigenesis
29. Immunohistochemical localization of glucose transporters in human renal cell carcinoma
30. Renal-cell carcinoma
31. Kidney cancer
32. Mutations of the VHL tumour suppressor gene in renal carcinoma
33. The pVHL-associated, SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinoma
34. Expression of hypoxia-inducible factor 1α in brain tumors
35. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas
36. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas
37. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
38. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
39. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function
40. Expression of vascular endothelial growth factor in renal cell carcinomas
41. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma
42. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis
43. Vascular endothelial growth factor expression is increased in renal cell carcinoma
44. Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: An in vivo study on 29 tumors
45. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
46. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences
47. Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2α
48. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer
49. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration
50. Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth